Retrospective and prospective researches of the biomarkers associated with adjuvant chemotherapy in patients with resectable pancreatic cancer

Retrospective and prospective researches of the biomarkers associated with adjuvant chemotherapy in patients with resectable pancreatic cancer - A research of the biomarkers associated with adjuvant chemotherapy in patients with resectable pancreatic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004612

Enrollment

100

Registered

2010-11-24

Start date

2009-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Surgicaly resected and histologically proven ductal pancreatic cancer 2) Age of more than 20 years Oral intake is possible 3) ECOG performance status (PS) of 0 to 2 4) Oral intake is possible 5) Adequate organ function 6) Written informed

Exclusion criteria

Exclusion criteria: 1)Intestinal pneumonia or lung fibrosis 2) No previous adjvant therapy 3) Severe diarrhea 4) Severe mental disorder 5) Active infection 6) Severe complication disease 7) Sever postoperative complications 8) History of chest radiotherapy 9) intractable pleural or abdominal effusion 10) Distant metastasis 11) History of other active malignancy 12) Pregnacy or patient's hope to be pregnant 13) Inadequate physical condition, as diagnosed by primary physician

Design outcomes

Primary

Measure	Time frame
Relapse-free survival	—

Secondary

Measure	Time frame
Overall survival	—

Countries

Japan

Contacts

Public ContactShibata Nobuhiro

University of Miyazaki Hospital Department of Medical Oncology

n-shiba@med.miyazaki-u.ac.jp0985-85-1419

Outcome results